# Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis

> **NCT07717697** · — · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 425 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Diabetic Kidney Disease

## Interventions

- **DRUG:** Finerenone

## Key facts

- **NCT ID:** NCT07717697
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2029-01-30
- **Final completion:** 2029-01-30
- **Target enrollment:** 425 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717697, "Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*